PARP1 and cancer: The ever-expanding efforts to understand the multifaceted regulation of DNA damage repair are identifying novel and effective synthetic lethality combinations to increase the responsiveness of cancers, particularly those having efficient DNA repair machinery that are otherwise resistant to DNA damage–inducing approaches such as irradiation or PARP inhibitor (31, 32).